A cell-free nanobody engineering platform rapidly generates SARS-CoV-2 neutralizing nanobodies
Abstract Antibody engineering technologies face increasing demands for speed, reliability and scale. We develop CeVICA, a cell-free nanobody engineering platform that uses ribosome display for in vitro selection of nanobodies from a library of 10 11 randomized sequences. We apply CeVICA to engineer...
में बचाया:
| मुख्य लेखकों: | , , , |
|---|---|
| स्वरूप: | Artigo |
| भाषा: | अंग्रेज़ी |
| प्रकाशित: |
2021
|
| ऑनलाइन पहुंच: | https://doi.org/10.1038/s41467-021-25777-z https://www.nature.com/articles/s41467-021-25777-z.pdf |
| टैग: |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|